...
首页> 外文期刊>Annals of Nutrition & Metabolism >The Effect of Bifidobacterium lactis on the Growth of Infants: A Pooled Analysis of Randomized Controlled Studies.
【24h】

The Effect of Bifidobacterium lactis on the Growth of Infants: A Pooled Analysis of Randomized Controlled Studies.

机译:乳酸双歧杆菌对婴儿生长的影响:随机对照研究的汇总分析。

获取原文
获取原文并翻译 | 示例
           

摘要

Background/Aims: Breast milk is the best source of nutrition for the growth of the newborn infant. It is therefore essential that mothers who cannot breastfeed or choose not to are provided with alternatives that closely match the composition and functionality of breast milk. This study aimed to investigate the growth effects of probiotic-supplemented formulas on both healthy and vulnerable populations of infants. Methods: A meta-analysis of data from 5 randomized controlled clinical trials that included infants fed formulas containing a probiotic Bifidobacterium lactis CNCM I-3446 was performed (n = 525). A sub-analysis was performed among infants of HIV-positive mothers (n = 120). Growth measurements (gain in weight and body mass index, BMI, from enrollment to 120 days) were compared between infants fed a formula containing B. lactis and those fed a control formula. Changes in length and Z-scores were also compared. Results: Formula with B.lactis was demonstrated to be at least as good as formula without B. lactis in the meta-analysis of 5 studies. The lower boundary of the 95% confidence interval (CI) of the differences in mean weight gain (95% CI 0.09-2.93 g/day) was above the predefined non-inferiority margin of -3.0 g/day. Moreover, among infants with HIV-positive mothers, weight gain of those taking B. lactis was significantly higher than of those not taking B. lactis, by 3.1 g/day (95% CI 0.4-5.8 g/day, p = 0.0226) and the BMI gains were significantly higher, by 6.4 g/m2/day (95% CI 0.0.3-12.5 g/m2/day, p = 0.0400). The corresponding weight for age and BMI Z-scores were also significantly higher, by 0.37 (95% CI 0.03-0.71, p = 0.0308) and by 0.42 (95% CI 0.02-0.83, p = 0.0377), respectively, whereas differences in length gain or length-for-age Z-score were not significant. Among infants in the non-HIV mothers group, there were no significant differences between infants fed formulas with or without B. lactis, for any of the growth parameters. Conclusions: The analysis suggests that B. lactis may have a positive effect on growth in vulnerable populations, specifically in infants born to mothers with HIV.
机译:背景/目的:母乳是新生儿生长的最佳营养来源。因此,必须为无法母乳喂养或选择不哺乳的母亲提供与母乳的成分和功能紧密匹配的替代品。这项研究旨在调查补充益生菌配方食品对健康和脆弱人群的生长效果。方法:对来自5个随机对照临床试验的数据进行了荟萃分析,包括婴儿喂养的含有益生菌乳酸双歧杆菌CNCM I-3446的配方食品(n = 525)。在HIV阳性母亲的婴儿(n = 120)中进行了子分析。在喂食含乳杆菌的婴儿配方奶粉和对照奶粉的婴儿之间,比较了其生长测量值(从入组到120天的体重和体重指数,体重指数)。还比较了长度和Z得分的变化。结果:在5项研究的荟萃分析中,含乳杆菌的配方与不含乳杆菌的配方至少一样好。平均体重增加差异(95%CI 0.09-2.93 g /天)的95%置信区间(CI)的下边界高于-3.0 g /天的预定义非劣质性边缘。此外,在具有HIV阳性母亲的婴儿中,服用乳杆菌的婴儿的体重增加比不服用乳杆菌的婴儿的体重增加显着高出3.1 g /天(95%CI 0.4-5.8 g /天,p = 0.0226)并且BMI增幅明显更高,达6.4 g / m2 /天(95%CI 0.0.3-12.5 g / m2 /天,p = 0.0400)。年龄和BMI Z评分的相应权重也分别显着提高,分别为0.37(95%CI 0.03-0.71,p = 0.0308)和0.42(95%CI 0.02-0.83,p = 0.0377),而长度增加或年龄长度Z分数均不显着。在非HIV母亲组的婴儿中,就任何生长参数而言,饲喂含或不含乳杆菌的配方食品的婴儿之间均无显着差异。结论:该分析表明,乳酸杆菌可对脆弱人群的生长产生积极影响,特别是对艾滋病毒母亲所生婴儿。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号